Coya Therapeutics (COYA) Operating Margin (2023 - 2025)
Historic Operating Margin for Coya Therapeutics (COYA) over the last 3 years, with Q3 2025 value amounting to 68.26%.
- Coya Therapeutics' Operating Margin changed N/A to 68.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 516.7%, marking a year-over-year decrease of 3978600.0%. This contributed to the annual value of 485.35% for FY2024, which is 3536800.0% down from last year.
- As of Q3 2025, Coya Therapeutics' Operating Margin stood at 68.26%.
- In the past 5 years, Coya Therapeutics' Operating Margin ranged from a high of 30.24% in Q4 2023 and a low of 209031.51% during Q4 2024
- Its 3-year average for Operating Margin is 31483.46%, with a median of 2976.89% in 2025.
- In the last 5 years, Coya Therapeutics' Operating Margin crashed by 2000000000bps in 2024 and then surged by 13459500bps in 2025.
- Over the past 3 years, Coya Therapeutics' Operating Margin (Quarter) stood at 30.24% in 2023, then plummeted by -691308bps to 209031.51% in 2024, then surged by 100bps to 68.26% in 2025.
- Its Operating Margin was 68.26% in Q3 2025, compared to 3920.47% in Q2 2025 and 2976.89% in Q1 2025.